$SCYX
SCYNEXIS INC

2021 Q4 Form 10-K Financial Statement

#000156459022012199 Filed on March 29, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $597.0K $13.16M $0.00
YoY Change
Cost Of Revenue $167.0K $312.0K
YoY Change
Gross Profit $430.0K $12.85M
YoY Change
Gross Profit Margin 72.03% 97.63%
Selling, General & Admin $15.04M $49.92M $5.180M
YoY Change 190.29% 241.26% 64.44%
% of Gross Profit 3496.98% 388.42%
Research & Development $7.690M $23.77M $10.16M
YoY Change -24.31% -34.9% -7.3%
% of Gross Profit 1788.37% 184.99%
Depreciation & Amortization $246.0K $200.0K $30.00K
YoY Change 720.0% 0.0% 50.0%
% of Gross Profit 57.21% 1.56%
Operating Expenses $22.73M $74.00M $15.34M
YoY Change 48.16% 44.68% 8.72%
Operating Profit -$22.30M -$60.84M
YoY Change 18.94%
Interest Expense -$6.959M $27.60M -$26.37M
YoY Change -73.61% 2236.66% 2862.92%
% of Operating Profit
Other Income/Expense, Net $13.00K $24.88M -$50.00K
YoY Change -126.0% -446.38% -109.26%
Pretax Income -$29.24M -$36.00M -$42.72M
YoY Change -31.55% -38.25% 195.44%
Income Tax $0.00 -$3.088M $0.00
% Of Pretax Income
Net Earnings -$29.24M -$32.87M -$42.71M
YoY Change -31.53% -40.44% 195.37%
Net Earnings / Revenue -4898.32% -249.68%
Basic Earnings Per Share -$1.25
Diluted Earnings Per Share -$1.079M -$1.246M -$3.420M
COMMON SHARES
Basic Shares Outstanding 26.38M
Diluted Shares Outstanding 26.38M

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $104.5M $104.5M $93.00M
YoY Change 12.35% 12.35% 92.15%
Cash & Equivalents $104.5M $104.5M $93.04M
Short-Term Investments
Other Short-Term Assets $4.000K $3.569M $373.0K
YoY Change -98.93% 55.17% -44.66%
Inventory $463.0K $463.0K $0.00
Prepaid Expenses
Receivables $861.0K $861.0K $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $109.4M $109.4M $98.21M
YoY Change 11.38% 11.38% 87.41%
LONG-TERM ASSETS
Property, Plant & Equipment $113.0K $2.914M $298.0K
YoY Change -62.08% -11.7% -26.42%
Goodwill
YoY Change
Intangibles $1.056M $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.235M $6.490M $573.0K
YoY Change 988.13% 549.0% -29.43%
Total Long-Term Assets $10.46M $10.46M $4.330M
YoY Change 141.57% 143.26% -8.86%
TOTAL ASSETS
Total Short-Term Assets $109.4M $109.4M $98.21M
Total Long-Term Assets $10.46M $10.46M $4.330M
Total Assets $119.8M $119.8M $102.5M
YoY Change 16.87% 16.91% 79.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.848M $7.848M $4.639M
YoY Change 69.17% 70.61% -35.36%
Accrued Expenses $5.698M $5.768M $4.141M
YoY Change 37.6% 37.33% 8.95%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $13.62M $13.62M $26.40M
YoY Change -48.42% -48.42% 139.66%
LONG-TERM LIABILITIES
Long-Term Debt $40.35M $40.35M $16.50M
YoY Change 144.56% 144.56%
Other Long-Term Liabilities $3.345M $24.61M $0.00
YoY Change -33.3% -100.0%
Total Long-Term Liabilities $3.345M $64.96M $0.00
YoY Change 21.65%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.62M $13.62M $26.40M
Total Long-Term Liabilities $3.345M $64.96M $0.00
Total Liabilities $78.58M $78.58M $79.78M
YoY Change -1.5% -1.53% 80.26%
SHAREHOLDERS EQUITY
Retained Earnings -$359.5M -$326.6M
YoY Change 10.06% 20.33%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $41.26M $41.26M $22.76M
YoY Change
Total Liabilities & Shareholders Equity $119.8M $119.8M $102.5M
YoY Change 16.87% 16.91% 79.41%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$29.24M -$32.87M -$42.71M
YoY Change -31.53% -40.44% 195.37%
Depreciation, Depletion And Amortization $246.0K $200.0K $30.00K
YoY Change 720.0% 0.0% 50.0%
Cash From Operating Activities -$25.52M -$54.56M -$16.57M
YoY Change 54.01% 10.55% 23.11%
INVESTING ACTIVITIES
Capital Expenditures -$583.0K $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$583.0K -$1.172M $0.00
YoY Change -118.1% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $38.55M
YoY Change -57.43%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 30.48M 67.12M 80.12M
YoY Change -61.96% -28.6% 137.6%
NET CHANGE
Cash From Operating Activities -25.52M -54.56M -16.57M
Cash From Investing Activities -583.0K -1.172M 0.000
Cash From Financing Activities 30.48M 67.12M 80.12M
Net Change In Cash 4.375M 11.39M 63.55M
YoY Change -93.12% -77.72% 109.74%
FREE CASH FLOW
Cash From Operating Activities -$25.52M -$54.56M -$16.57M
Capital Expenditures -$583.0K $0.00 $0.00
Free Cash Flow -$24.94M -$54.56M -$16.57M
YoY Change 50.49% 10.54% 23.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2018Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2020Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2018Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-36365
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
56-2181648
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
1 Evertrust Plaza
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
13th Floor
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Jersey City
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07302 - 6548
CY2021 dei City Area Code
CityAreaCode
201
CY2021 dei Local Phone Number
LocalPhoneNumber
884-5485
CY2021 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
168966957
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2220000
CY2020 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
28000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
57184000
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
5222000
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
208000
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y7M2D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y7M2D
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.00
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y8M15D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y5M12D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y10M28D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y5M12D
CY2021 dei Auditor Firm
AuditorFirmId
34
CY2021 dei Auditor Name
AuditorName
DELOITTE & TOUCHE LLP
CY2021 dei Auditor Location
AuditorLocation
Parsippany, New Jersey
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104484000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93041000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3569000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5165000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
861000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0
CY2021Q4 us-gaap Inventory Net
InventoryNet
463000
CY2020Q4 us-gaap Inventory Net
InventoryNet
0
CY2021Q4 us-gaap Assets Current
AssetsCurrent
109377000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
98206000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6122000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
573000
CY2021Q4 us-gaap Deferred Costs
DeferredCosts
150000
CY2020Q4 us-gaap Deferred Costs
DeferredCosts
187000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
218000
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
273000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
113000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
298000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1056000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2801000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2999000
CY2021Q4 us-gaap Assets
Assets
119837000
CY2020Q4 us-gaap Assets
Assets
102536000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7848000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4639000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5698000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4141000
CY2021Q4 scyx Warrant Liabilities Current
WarrantLiabilitiesCurrent
0
CY2020Q4 scyx Warrant Liabilities Current
WarrantLiabilitiesCurrent
17564000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
70000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
52000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13616000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
26396000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3345000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10720211
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
18062000
CY2020Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
33592000
CY2021Q4 scyx Convertible Debt And Derivative Liability
ConvertibleDebtAndDerivativeLiability
11607000
CY2020Q4 scyx Convertible Debt And Derivative Liability
ConvertibleDebtAndDerivativeLiability
16516000
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
28745000
CY2020Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
0
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3204000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3274000
CY2021Q4 us-gaap Liabilities
Liabilities
78579000
CY2020Q4 us-gaap Liabilities
Liabilities
79778000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2020Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28705334
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28705334
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19663698
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19663698
CY2021Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
32000
CY2020Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
20000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
400705000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
349351000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-359479000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-326613000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
41258000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
22758000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
119837000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
102536000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
49916000
CY2021 us-gaap Operating Expenses
OperatingExpenses
74001000
CY2020 us-gaap Operating Expenses
OperatingExpenses
51149000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-60838000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-51149000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1766000
CY2020 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
334000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
24884000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7184000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-35954000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-58333000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3088000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3148000
CY2021 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-1.25
CY2020 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-5.15
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26384713
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
12895000
CY2020 scyx Common Stock Value Issued For Commitment Shares
CommonStockValueIssuedForCommitmentShares
602000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
22758000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-32866000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2088000
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
22000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
41040000
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
7453000
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
3000
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
766000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
41258000
CY2021 us-gaap Profit Loss
ProfitLoss
-32866000
CY2020 us-gaap Profit Loss
ProfitLoss
-55185000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
379000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
111000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2088000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2220000
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1303000
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1201000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-30365000
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5214000
CY2021 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1170000
CY2020 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
2257000
CY2021 scyx Noncash Operating Lease Expenses For Right Of Use Asset
NoncashOperatingLeaseExpensesForRightOfUseAsset
198000
CY2020 scyx Noncash Operating Lease Expenses For Right Of Use Asset
NoncashOperatingLeaseExpensesForRightOfUseAsset
192000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2725000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1766000
CY2021 scyx Noncash Consideration Associated With Common Stock Purchase Agreement
NoncashConsiderationAssociatedWithCommonStockPurchaseAgreement
0
CY2020 scyx Noncash Consideration Associated With Common Stock Purchase Agreement
NoncashConsiderationAssociatedWithCommonStockPurchaseAgreement
602000
CY2021 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1597000
CY2020 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
922000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
861000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5292000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2763000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2600000
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
4941000
CY2020 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
304000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-54560000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-49354000
CY2021 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
0
CY2020 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
20713000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4000
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1172000
CY2020 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
CY2021 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
0
CY2020 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
14235000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1172000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
6474000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
38552000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
90554000
CY2021 scyx Payments Of Offering Costs And Underwriting Discounts And Commissions
PaymentsOfOfferingCostsAndUnderwritingDiscountsAndCommissions
205000
CY2020 scyx Payments Of Offering Costs And Underwriting Discounts And Commissions
PaymentsOfOfferingCostsAndUnderwritingDiscountsAndCommissions
5879000
CY2021 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
30000000
CY2020 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0
CY2021 us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
1253000
CY2020 us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
0
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
22000
CY2020 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
28000
CY2021 scyx Payments For Proceeds From Repurchase Of Shares To Satisfy Tax Withholdings
PaymentsForProceedsFromRepurchaseOfSharesToSatisfyTaxWithholdings
-4000
CY2020 scyx Payments For Proceeds From Repurchase Of Shares To Satisfy Tax Withholdings
PaymentsForProceedsFromRepurchaseOfSharesToSatisfyTaxWithholdings
208000
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
CY2020 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
10000000
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
CY2020 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
494000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
67120000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
94001000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
11388000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
51121000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93314000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42193000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104702000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93314000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
2255000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
1088000
CY2021 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
24000
CY2020 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
186000
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
78000
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0
CY2021 scyx Deferred Offering And Issuance Costs Included In Accounts Payable
DeferredOfferingAndIssuanceCostsIncludedInAccountsPayable
430000
CY2020 scyx Deferred Offering And Issuance Costs Included In Accounts Payable
DeferredOfferingAndIssuanceCostsIncludedInAccountsPayable
62000
CY2021 scyx Deferred Offering Costs Reclassified To Additional Paid In Capital
DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital
86000
CY2020 scyx Deferred Offering Costs Reclassified To Additional Paid In Capital
DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital
153000
CY2021 us-gaap Stock Issued1
StockIssued1
7452000
CY2020 us-gaap Stock Issued1
StockIssued1
5221000
CY2021 scyx Common Stock Issued For Commitment Shares
CommonStockIssuedForCommitmentShares
0
CY2020 scyx Common Stock Issued For Commitment Shares
CommonStockIssuedForCommitmentShares
602000
CY2021 scyx Reclass Of Warrant Liability To Additional Paid In Capital
ReclassOfWarrantLiabilityToAdditionalPaidInCapital
298000
CY2020 scyx Reclass Of Warrant Liability To Additional Paid In Capital
ReclassOfWarrantLiabilityToAdditionalPaidInCapital
0
CY2021 scyx Reclass Of Deferred Asset Issuance Of Loan Payable To Debt Discount
ReclassOfDeferredAssetIssuanceOfLoanPayableToDebtDiscount
390000
CY2020 scyx Reclass Of Deferred Asset Issuance Of Loan Payable To Debt Discount
ReclassOfDeferredAssetIssuanceOfLoanPayableToDebtDiscount
0
CY2021 scyx Settlement Of Liability For Exercise Of Warrants
SettlementOfLiabilityForExerciseOfWarrants
3091000
CY2020 scyx Settlement Of Liability For Exercise Of Warrants
SettlementOfLiabilityForExerciseOfWarrants
0
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-359500000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
104500000
CY2020Q4 scyx Shelf Registration Maximum Equity Offering Price
ShelfRegistrationMaximumEquityOfferingPrice
200000000.0
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
105083291
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
105083291
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10508302
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10508302
CY2020Q3 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
0
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:6pt;margin-top:6pt;margin-left:3.47%;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-bottom:6pt;margin-top:6pt;text-indent:3.47%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments, which potentially expose the Company to concentrations of credit risk, consist principally of cash on deposit and cash equivalents and accounts receivable.  The Company's money market fund investment (recognized as cash and cash equivalents) is with what the Company believes to be a high quality issuer. The Company has not experienced any significant losses in the account.  See Note 11 for concentrations of credit risk associated with the Company’s accounts receivable and revenue with customers.</p>
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104700000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93300000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
0
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3000
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
0
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
127000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
0
CY2021Q4 scyx Inventory Current And Noncurrent Net
InventoryCurrentAndNoncurrentNet
5292000
CY2020Q4 scyx Inventory Current And Noncurrent Net
InventoryCurrentAndNoncurrentNet
0
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="margin-bottom:6pt;margin-top:0pt;text-indent:3.47%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#F9F9F9;">Reclassification of Prior Year Amounts</span></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.47%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#F9F9F9;">Certain prior year amounts have been reclassified for consistency with the current year presentation.</span></p>
CY2021Q4 scyx Prepaid Researchand Development Expenses Current
PrepaidResearchandDevelopmentExpensesCurrent
247000
CY2020Q4 scyx Prepaid Researchand Development Expenses Current
PrepaidResearchandDevelopmentExpensesCurrent
1535000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
505000
CY2020Q4 us-gaap Prepaid Insurance
PrepaidInsurance
362000
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
2813000
CY2020Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
19000
CY2020Q4 us-gaap Other Receivables
OtherReceivables
2876000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
373000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3569000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5165000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5162000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
580000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
580000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
467000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
282000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
113000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
298000
CY2021 us-gaap Depreciation
Depreciation
200000
CY2020 us-gaap Depreciation
Depreciation
200000
CY2021 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P3Y
CY2021 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P3Y
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
400000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
400000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1250000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
194000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1056000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
200000
CY2021Q4 scyx Accrued Researchand Development Expense Current
AccruedResearchandDevelopmentExpenseCurrent
1498000
CY2020Q4 scyx Accrued Researchand Development Expense Current
AccruedResearchandDevelopmentExpenseCurrent
991000
CY2021Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2012000
CY2020Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2190000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1352000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
960000
CY2021Q4 scyx Accrued Rebates Current
AccruedRebatesCurrent
836000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5698000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4141000
CY2021Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
20000000.0
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
500000
CY2021Q2 scyx Fair Value Of Initial Warrant Liabilities Recorded As Deferred Asset And Reclassified To Debt Discount
FairValueOfInitialWarrantLiabilitiesRecordedAsDeferredAssetAndReclassifiedToDebtDiscount
700000
CY2021 us-gaap Debt Instrument Description
DebtInstrumentDescription
Upon the funding of the $10.0 million for the second tranche in June 2021, the associated warrant liability of $0.3 million was reclassed to additional paid in capital at settlement and 56,803 shares of common stock were issued.
CY2021Q2 scyx Reclass Of Warrant Liability To Additional Paid In Capital
ReclassOfWarrantLiabilityToAdditionalPaidInCapital
300000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
20737000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
9263000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
30000000
CY2021Q4 scyx Debt Instrument Final Fee Due At Maturity
DebtInstrumentFinalFeeDueAtMaturity
1185000
CY2021Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
31185000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
2440000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
28745000
CY2020Q2 us-gaap Debt Instrument Offering Date1
DebtInstrumentOfferingDate1
2020-04-09
CY2020Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
10000000.0
CY2020Q2 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
9500000
CY2020Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
500000
CY2020Q2 scyx Debt Instrument Purchase Price As Percentage Of Principal Amount
DebtInstrumentPurchasePriceAsPercentageOfPrincipalAmount
1
CY2020Q2 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
2000000.0
CY2020Q4 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
2000000.0
CY2020Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
316461
CY2020Q4 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
322348
CY2020 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
4000000.0
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
800000
CY2020Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1000000.0
CY2021Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
6000000.0
CY2021Q1 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
959080
CY2021Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
6000000.0
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2700000
CY2021 us-gaap Debt Instrument Payment Terms
DebtInstrumentPaymentTerms
The April 2020 Notes incurred interest at a rate of 6.0% per annum, payable semiannually in arrears on April 15 and October 15 of each year, beginning October 15, 2020.
CY2020Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.060
CY2020Q4 scyx Convertible Debt And Derivative Liability Fair Value Disclosures
ConvertibleDebtAndDerivativeLiabilityFairValueDisclosures
7400000
CY2018Q1 scyx Lease Agreement Area Of Office Space
LeaseAgreementAreaOfOfficeSpace
19275
CY2018Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P11Y
CY2018Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
7300000
CY2018Q1 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
The Company has the option to renew for two consecutive five-year periods from the end of the first term and the Company is not reasonably certain that the option to renew the Lease will be exercised. Under the Lease, the Company furnished a security deposit in the form of a standby letter of credit in the amount of $0.3 million, which will be reduced by fifty-five thousand dollars every two years for ten years after the commencement of the lease
CY2018Q1 us-gaap Security Deposit
SecurityDeposit
300000
CY2018Q1 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
55000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
664000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
664000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
38000
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
51000
CY2021 us-gaap Lease Cost
LeaseCost
702000
CY2020 us-gaap Lease Cost
LeaseCost
715000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
517000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
507000
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.15
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.15
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
527000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
715000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
730000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
744000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
759000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
2030000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5505000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3274000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
70000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3204000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3274000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2231000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28705334
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28705334
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19663698
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19663698
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2021 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-10
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q3 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
0
CY2020Q3 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
0
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
14367493
CY2020Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
28028978
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.002
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1775150
CY2016Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
937500
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-30400000
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5200000
CY2021Q4 scyx Fair Value Of Liabilities
FairValueOfLiabilities
18100000
CY2020Q2 scyx Increase In Sale Of Common Stock Maximum Number Of Share Sold Per Business Day
IncreaseInSaleOfCommonStockMaximumNumberOfShareSoldPerBusinessDay
200000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2021 scyx Contract With Customer Liability Provision Related To Current Period Revenue
ContractWithCustomerLiabilityProvisionRelatedToCurrentPeriodRevenue
3106000
CY2021 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
0
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1726000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1380000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3100000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3100000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36000000.0
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-58300000
CY2021 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
-4188000
CY2020 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
-3148000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1100000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-3088000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-3148000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-7781000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-12250000
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1144000
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.031
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-4108000
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.070
CY2021 scyx Income Tax Reconciliation State Effect Of Permanent Items
IncomeTaxReconciliationStateEffectOfPermanentItems
-906000
CY2021 scyx Effective Income Tax Rate Reconciliation State Effect Of Permanent Items
EffectiveIncomeTaxRateReconciliationStateEffectOfPermanentItems
0.024
CY2020 scyx Income Tax Reconciliation State Effect Of Permanent Items
IncomeTaxReconciliationStateEffectOfPermanentItems
78000
CY2020 scyx Effective Income Tax Rate Reconciliation State Effect Of Permanent Items
EffectiveIncomeTaxRateReconciliationStateEffectOfPermanentItems
-0.001
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
1100000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.030
CY2020 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
114000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.003
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
96000
CY2021 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
339000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.009
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2021 scyx Effective Income Tax Rate Reconciliation Issuance Of Warrants
EffectiveIncomeTaxRateReconciliationIssuanceOfWarrants
-6622000
CY2021 scyx Effective Income Tax Rate Reconciliation Issuance Of Warrants Percent
EffectiveIncomeTaxRateReconciliationIssuanceOfWarrantsPercent
0.179
CY2020 scyx Effective Income Tax Rate Reconciliation Issuance Of Warrants
EffectiveIncomeTaxRateReconciliationIssuanceOfWarrants
131000
CY2020 scyx Effective Income Tax Rate Reconciliation Issuance Of Warrants Percent
EffectiveIncomeTaxRateReconciliationIssuanceOfWarrantsPercent
-0.002
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-489000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.013
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
206000
CY2021 scyx Income Tax Reconciliation Net Operating Loss Sale
IncomeTaxReconciliationNetOperatingLossSale
214000
CY2021 scyx Effective Income Tax Rate Reconciliation Net Operating Loss Sale
EffectiveIncomeTaxRateReconciliationNetOperatingLossSale
-0.006
CY2020 scyx Income Tax Reconciliation Net Operating Loss Sale
IncomeTaxReconciliationNetOperatingLossSale
301000
CY2020 scyx Effective Income Tax Rate Reconciliation Net Operating Loss Sale
EffectiveIncomeTaxRateReconciliationNetOperatingLossSale
-0.005
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0
CY2020 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
-2000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
12087000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.326
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
12396000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.213
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3088000
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.083
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3148000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.057
CY2021Q4 scyx Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Expenses Noncurrent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedExpensesNoncurrent
1264000
CY2020Q4 scyx Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Expenses Noncurrent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedExpensesNoncurrent
148000
CY2021Q4 scyx Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Noncurrent
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCostNoncurrent
2554000
CY2020Q4 scyx Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Noncurrent
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCostNoncurrent
2591000
CY2021Q4 scyx Deferred Tax Assets Tax Deferred Expense Lease Liability
DeferredTaxAssetsTaxDeferredExpenseLeaseLiability
789000
CY2020Q4 scyx Deferred Tax Assets Tax Deferred Expense Lease Liability
DeferredTaxAssetsTaxDeferredExpenseLeaseLiability
935000
CY2021Q4 scyx Deferred Tax Liabilities Other Noncurrent
DeferredTaxLiabilitiesOtherNoncurrent
757000
CY2020Q4 scyx Deferred Tax Liabilities Other Noncurrent
DeferredTaxLiabilitiesOtherNoncurrent
823000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
80453000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
70936000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
6839000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
5291000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
91142000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
79078000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
91142000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
79078000
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2021 scyx Tax Cuts And Job Acts Of2017 Temporary Expense For Certain Business Assets And Property Percentage
TaxCutsAndJobActsOf2017TemporaryExpenseForCertainBusinessAssetsAndPropertyPercentage
1
CY2021 scyx Tax Cuts And Jobs Act Of2017 Maximum Percentage Of Pre Net Operating Loss Deduction Taxable Income Limit For Net Operating Loss Deduction
TaxCutsAndJobsActOf2017MaximumPercentageOfPreNetOperatingLossDeductionTaxableIncomeLimitForNetOperatingLossDeduction
0.80
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
14.89
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
42000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1600000
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1300000
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3500000
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y8M12D
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
436000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
436000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0
CY2021 scyx Unrecognized Tax Benefits Decreases Resulting From Deferred Rate Change
UnrecognizedTaxBenefitsDecreasesResultingFromDeferredRateChange
0
CY2020 scyx Unrecognized Tax Benefits Decreases Resulting From Deferred Rate Change
UnrecognizedTaxBenefitsDecreasesResultingFromDeferredRateChange
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
436000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
436000
CY2021Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2021Q4 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
0
CY2021Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.63
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.83
CY2021 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
4000000.0
CY2020 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
1700000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
830343
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
21.52
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
96000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
874050
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.30
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
162267
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
7.95
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1542126
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.89
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
42000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
739332
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
22.73
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
11000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1542126
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2100000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2200000
CY2021 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2020 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2088000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2220000
CY2021 scyx Defined Contribution Plan Required Work Hours Per Week
DefinedContributionPlanRequiredWorkHoursPerWeek
20
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2021 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.06
CY2021 scyx Defined Contribution Plan Employers Matching Contribution Vesting Period
DefinedContributionPlanEmployersMatchingContributionVestingPeriod
P4Y
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
100000
CY2020 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
100000

Files In Submission

Name View Source Status
0001564590-22-012199-index-headers.html Edgar Link pending
0001564590-22-012199-index.html Edgar Link pending
0001564590-22-012199.txt Edgar Link pending
0001564590-22-012199-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gozczdoeswry000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
scyx-10k_20211231.htm Edgar Link pending
scyx-10k_20211231_htm.xml Edgar Link completed
scyx-20211231.xsd Edgar Link pending
scyx-20211231_cal.xml Edgar Link unprocessable
scyx-20211231_def.xml Edgar Link unprocessable
scyx-20211231_lab.xml Edgar Link unprocessable
scyx-20211231_pre.xml Edgar Link unprocessable
scyx-ex231_8.htm Edgar Link pending
scyx-ex311_7.htm Edgar Link pending
scyx-ex312_6.htm Edgar Link pending
scyx-ex321_9.htm Edgar Link pending
scyx-ex42_10.htm Edgar Link pending
Show.js Edgar Link pending